Home LiteratureArticle Details
PMID: 15232616 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

PPARalpha governs glycerol metabolism.

The Journal of clinical investigation ·Vol. 114 ·No. 1 ·2004-07-00 ·Pages 94-103

Patsouris D, Mandard S, Voshol PJ, Escher P, Tan NS, Havekes LM, Koenig W, März W, Tafuri S, Wahli W, Müller M, Kersten S

Abstract

Glycerol, a product of adipose tissue lipolysis, is an important substrate for hepatic glucose synthesis. However, little is known about the regulation of hepatic glycerol metabolism. Here we show that several genes involved in the hepatic metabolism of glycerol, i.e., cytosolic and mitochondrial glycerol 3-phosphate dehydrogenase (GPDH), glycerol kinase, and glycerol transporters aquaporin 3 and 9, are upregulated by fasting in wild-type mice but not in mice lacking PPARalpha. Furthermore, expression of these genes was induced by the PPARalpha agonist Wy14643 in wild-type but not PPARalpha-null mice. In adipocytes, which express high levels of PPARgamma, expression of cytosolic GPDH was enhanced by PPARgamma and beta/delta agonists, while expression was decreased in PPARgamma(+/-) and PPARbeta/delta(-/-) mice. Transactivation, gel shift, and chromatin immunoprecipitation experiments demonstrated that cytosolic GPDH is a direct PPAR target gene. In line with a stimulating role of PPARalpha in hepatic glycerol utilization, administration of synthetic PPARalpha agonists in mice and humans decreased plasma glycerol. Finally, hepatic glucose production was decreased in PPARalpha-null mice simultaneously fasted and exposed to Wy14643, suggesting that the stimulatory effect of PPARalpha on gluconeogenic gene expression was translated at the functional level. Overall, these data indicate that PPARalpha directly governs glycerol metabolism in liver, whereas PPARgamma regulates glycerol metabolism in adipose tissue.

MeSH Terms
3T3 Cells Animals Base Sequence Carcinoma, Hepatocellular Cell Line, Tumor Cloning, Molecular DNA Primers Gene Expression Regulation Glycerol/metabolism Homeostasis Humans Liver/metabolism Liver Neoplasms Mice Mice, Knockout Models, Animal Oligonucleotide Array Sequence Analysis Plasmids Receptors, Cytoplasmic and Nuclear/deficiency,genetics,physiology Recombinant Proteins/metabolism Transcription Factors/deficiency,genetics,physiology Transfection
Chemicals
DNA Primers Receptors, Cytoplasmic and Nuclear Recombinant Proteins Transcription Factors Glycerol
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Patsouris David
Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Mandard Stéphane
Voshol Peter J
Escher Pascal
Tan Nguan Soon
Havekes Louis M
Koenig Wolfgang
März Winfried
Tafuri Sherrie
Wahli Walter
Müller Michael
Kersten Sander
References (47)
47 references, click to expand
  1. Inhibition of glycerol metabolism in hepatocytes isolated from endotoxic rats.
    Biochem J. 1997 Jul 15;325 ( Pt 2):519-25 PMID: 9230136
  2. Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose.
    Am J Physiol. 1995 Sep;269(3 Pt 1):E516-23 PMID: 7573429
  3. C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver.
    J Biol Chem. 1998 Nov 27;273(48):31629-32 PMID: 9822619
  4. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.
    J Clin Invest. 1999 Feb;103(3):365-72 PMID: 9927497
  5. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    J Clin Invest. 1999 Jun;103(11):1489-98 PMID: 10359558
  6. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7473-8 PMID: 10377439
  7. Activation of PPARdelta alters lipid metabolism in db/db mice.
    FEBS Lett. 2000 May 19;473(3):333-6 PMID: 10818235
  8. Roles of PPARs in health and disease.
    Nature. 2000 May 25;405(6785):421-4 PMID: 10839530
  9. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
    Diabetes. 2000 May;49(5):701-7 PMID: 10905476
  10. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.
    J Biol Chem. 2000 Sep 15;275(37):28488-93 PMID: 10862772
  11. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    J Biol Chem. 2000 Sep 15;275(37):28918-28 PMID: 10844002
  12. Isolated and contiguous glycerol kinase gene disorders: a review.
    J Inherit Metab Dis. 2000 Sep;23(6):529-47 PMID: 11032329
  13. Molecular regulation of adipogenesis.
    Annu Rev Cell Dev Biol. 2000;16:145-71 PMID: 11031233
  14. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.
    Diabetes. 2001 Feb;50(2):411-7 PMID: 11272155
  15. Free fatty acids and pathogenesis of type 2 diabetes mellitus.
    Trends Endocrinol Metab. 2000 Nov;11(9):351-6 PMID: 11042464
  16. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation.
    Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15 PMID: 11244452
  17. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice.
    J Clin Invest. 2001 Apr;107(8):1025-34 PMID: 11306606
  18. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism.
    FASEB J. 2001 Sep;15(11):1971-8 PMID: 11532977
  19. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.
    J Biol Chem. 2001 Nov 2;276(44):41245-54 PMID: 11533050
  20. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
    Diabetes. 2001 Dec;50(12):2809-14 PMID: 11723064
  21. Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma.
    J Biol Chem. 2001 Dec 21;276(51):48572-9 PMID: 11679588
  22. PPAR(gamma) and glucose homeostasis.
    Annu Rev Nutr. 2002;22:167-97 PMID: 12055342
  23. WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.
    J Biol Chem. 2002 Jul 5;277(27):24484-9 PMID: 11994294
  24. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
    J Biol Chem. 2002 Jul 19;277(29):26089-97 PMID: 12118038
  25. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats.
    Biochem Biophys Res Commun. 2002 Aug 16;296(2):293-9 PMID: 12163016
  26. Lethal hypoglycemic ketosis and glyceroluria in mice lacking both the mitochondrial and the cytosolic glycerol phosphate dehydrogenases.
    J Biol Chem. 2002 Sep 6;277(36):32899-904 PMID: 12093800
  27. A futile metabolic cycle activated in adipocytes by antidiabetic agents.
    Nat Med. 2002 Oct;8(10):1122-8 PMID: 12357248
  28. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.
    Mol Cell. 2002 Oct;10(4):721-33 PMID: 12419217
  29. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.
    J Biol Chem. 2002 Dec 27;277(52):50237-44 PMID: 12176975
  30. Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver.
    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2945-50 PMID: 12594337
  31. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4012-7 PMID: 12651943
  32. Mechanisms of the free fatty acid-induced increase in hepatic glucose production.
    Am J Physiol Endocrinol Metab. 2003 May;284(5):E863-73 PMID: 12676648
  33. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.
    Cell. 2003 Apr 18;113(2):159-70 PMID: 12705865
  34. Antidyslipidemic action of fenofibrate in dyslipidemic-diabetic hamster model.
    Biochem Biophys Res Commun. 2003 May 30;305(2):215-22 PMID: 12745061
  35. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.
    Diabetes. 2003 Jul;52(7):1770-8 PMID: 12829645
  36. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice.
    Endocrinology. 2003 Aug;144(8):3456-62 PMID: 12865325
  37. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice.
    Nat Med. 2003 Aug;9(8):1069-75 PMID: 12847522
  38. Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
    Diabetes. 2003 Sep;52(9):2249-59 PMID: 12941763
  39. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Diabetes. 2003 Sep;52(9):2331-7 PMID: 12941773
  40. Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes.
    Biochimie. 2003 Dec;85(12):1213-8 PMID: 14739073
  41. Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast.
    J Biol Chem. 2004 Mar 5;279(10):8930-7 PMID: 14688286
  42. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.
    Endocrinology. 2004 Apr;145(4):1662-7 PMID: 14670996
  43. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells.
    J Biol Chem. 1979 Jan 25;254(2):273-5 PMID: 762059
  44. Role of endogenous fatty acids in the control of hepatic gluconeogenesis.
    Arch Biochem Biophys. 1992 Jan;292(1):95-101 PMID: 1727653
  45. Glycerol gluconeogenesis in fasting humans.
    Nutrition. 1995 Mar-Apr;11(2):149-53 PMID: 7647479
  46. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Diabetes. 1995 Sep;44(9):1038-45 PMID: 7657026
  47. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element.
    J Biol Chem. 1997 Aug 8;272(32):20108-17 PMID: 9242684
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2004-07-00
Pages
94-103
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC437964
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com